API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide-tablets-59973.pdf
https://www.statnews.com/pharmalot/2019/01/03/california-drug-prices-transparency-4/?utm_source=STAT+Newsletters&utm_campaign=b0cc66a241-Pharmalittle_COPY_01&utm_medium=email&utm_term=0_8cab1d7961-b0cc66a241-150630089
http://www.gilead.com/news/press-releases/2018/8/china-national-drug-administration-approves-gileads-genvoya-elvitegravir-cobicistat-emtricitabine-and-tenofovir-alafenamide-a-single-tablet-regimen-for-the-treatment-of-hiv1-infection
https://www.pharmacompass.com/pdf/news/truvada-emtricitabine-tenofovir-disoproxil-fumarateelvitegravir-gs-9350-cobicistat-viiv-healthcare-v-gilead-sciences-1518416906.pdf
http://seekingalpha.com/article/4033080-glaxo-gilead-hiv-battle-epic
https://www.pharmacompass.com/pdf/news/gilead-sciences-cobicistat-elvitegravir-emtricitabine-tenofovir-alafenamide-fumarate-approved-in-us-1474376630.pdf
http://www.fiercebiotech.com/story/gilead-gains-next-gen-hiv-approval-fda-it-looks-beat-back-competition/2016-04-05
http://www.fiercebiotech.com/story/gileads-latest-hiv-cocktail-wins-fda-approval-blockbuster-pedigree/2016-03-01
http://www.pharmatimes.com/Article/15-11-24/EU_clears_single_pill_HIV_therapy_Genvoya.aspx
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/06/nce-exclusivity-challenges-are-hot-hot-hot-ferring-lets-loose-with-the-latest-lawsuit-challenging-de.html
http://www.bizjournals.com/sanfrancisco/blog/biotech/2015/04/gilead-gild-hiv-aids-taf-tenofovir.html
http://www.gilead.com/news/press-releases/2015/2/gilead-announces-phase-3-results-for-investigational-oncedaily-single-tablet-hiv-regimen-containing-tenofovir-alafenamide-taf